Cystic fibrosis drug Kalydeco approved by FDA: What does it mean for patients?

Comments Off on Cystic fibrosis drug Kalydeco approved by FDA: What does it mean for patients? 231 Views

November study found Kalydeco improved lung function, reduced complications in patients with cystic fibrosis who have G551D mutation

FDA Approves First Targeted Drug against Cystic Fibrosis

Comments Off on FDA Approves First Targeted Drug against Cystic Fibrosis 498 Views

Image: Illustration by John Hendrix The U.S. Food and Drug Administration today approved a new drug that tackles the underlying cause of cystic fibrosis (CF) in 4 percent of patients . The drug, called ivacaftor (brand name Kalydeco), acts by helping the body make better use of a protein that works incorrectly in cystic fibrosis patients.

Video: Breakthrough in cystic fibrosis treatment

Comments Off on Video: Breakthrough in cystic fibrosis treatment 212 Views

The new drug Kalydeco is being hailed as a breakthrough in the treatment of cystic fibrosis, targeting the underlying genetic cause of the disease decreasing the symptoms. Dr. Jon LaPook reports.

Philippe Matthews Show Guru Advice, Author Reviews, Tech Reviews, Entertainment News

Tag Archives: kalydeco

Cystic fibrosis drug Kalydeco approved by FDA: What does it mean for patients?

FDA Approves First Targeted Drug against Cystic Fibrosis

Video: Breakthrough in cystic fibrosis treatment

1804 – Hidden History of Haiti Review

The Wakanda Affect

Race-Based Eroticized Rage: When Black Men Use White Women to Seek Racial Revenge